Shares were roughly flat, down 1.0% after earnings. Laureate reported quarterly revenue and adjusted EBITDA ahead of its prior guidance, helped by favorable foreign exchange, and reaffirmed full-year guidance; the transcript excerpt does not provide enough detail to assess the rest of the quarter’s financial picture.
- Third-quarter revenue was **$485 million** and adjusted EBITDA was **$147 million**, both ahead of guidance provided three months earlier; management cited favorable FX.
- New enrollment growth was **8% in Mexico** versus the comparable intake period and **9% in Peru** during the secondary intake, which is still underway.
- Total enrollment volumes increased **6%** for the current intake cycle, according to the CFO’s opening financial remarks.
- Management reaffirmed full-year guidance and announced a **$150 million increase** to the stock repurchase program.
- Laureate expects to open a Southern Lima campus in the first quarter and a campus in Mérida before Mexico’s September 2027 main intake; it also flagged potential operational disruption from El Niño in Peru from November 2026 to February 2027.
Community Discussion